MAPK3 and chronic myelogenous leukemia, BCR-ABL1 positive: This was confirmed by our analysis of tumor histological slides from athymic mice grafted with K562 CML cell lines, which clearly showed a complete inhibition of ERK1/2 phosphorylation in SkE-treated mice.